Ultragenyx
RARE
$44.24
Share price
0.89%
Change (1 day)
1.31%
Change (1 year)
Categories
Ultragenyx (RARE) Fails to deliver data
Key failure to deliver metrics for Ultragenyx:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.08 M
- Last 3 months FTD volume: $3.42 M
- Last year FTD volume: $16.85 M
Failures to deliver for Ultragenyx (RARE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Ultragenyx (RARE) - since 2014
Volume in USD (price x number of shares), data since 2014Ultragenyx (RARE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $3.41 M | -76.41% |
| 2023 | $14.48 M | 344.12% |
| 2022 | $3.26 M | -64.77% |
| 2021 | $9.26 M | -20.49% |
| 2020 | $11.64 M | -3.02% |
| 2019 | $12.01 M | -75.7% |
| 2018 | $49.42 M | -12.01% |
| 2017 | $56.16 M | -14.47% |
| 2016 | $65.66 M | -56.5% |
| 2015 | $0.15 B | 326.02% |
| 2014 | $35.43 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $14.09 M | $23.42 M | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $3.36 M | $8.49 M | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $1.7 M | $4.65 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |